Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
 |
New Vision (Kampala) - September 17, 2007
Esther Mukyala
In a report read out at the 11th annual general meeting of The AIDS Support Organisation (TASO) Jinja on Saturday, the clients thanked the Government for the support it was rendering the organisation. The day's theme was scaling up the HIV/Aids prevention.
"Clients are being treated with ARVs, Septrine prophylaxis and there is improvement in their health. But we appeal for more of those drugs because there are many people living with HIV/Aids," Sarah Kyesimira, a clients' representative said.
TASO Jinja Centre serves 6,825 clients with at least 1,820 of them on ARVs. A total of 92 are children.
"Under the Antiretroviral Therapy (ART), we have a total of 1,820 clients. 72.7% are female and 27.3% are male. We hope that 2,250 clients will be able to access ARTs by March 2008," the centre manager, Cissy Musumba, said in her report.
She observed that the disparity in the figures of people seeking TASO services was as a result of a higher health-seeking behaviour among the women. She appealed to the men to open up and go for the services.
The Kaliro district chairperson, Elijah Kagoda, expressed concern over the increasing number of deaths of people living with HIV yet Government's funding was insufficient.
He added that this was due to the increased population growth rate, progressive HIV prevalence which drains the limited available resources.
070917
NV070910
Copyright © 2007 - The New Vision. All articles are republished on AEGIS by permission. Material may not be redistributed, posted to any other location, published or used for broadcast without written authorization from Managing Director/Editor-in-chief, The New Vision, P.O. Box 9815, Kampala - Uganda, Tel/fax: 256-41-235221, E-mail: wpike@newvision.co.ug.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .